The Role of Cannabis in Migraine Treatment
Interview Notes – COMING SOON
- Nathaniel M. Schuster, MD
Treatments Mentioned – COMING SOON
Please note: The Migraine World Summit’s aim is to bring you a variety of perspectives and expertise, independent of bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.
Nathaniel M. Schuster, MD
Associate Clinic Director & Associate Professor
University of California, San Diego Center for Pain Medicine
Dr. Nathaniel Schuster is a headache and pain neurologist and an associate professor and associate clinic director at the University of California San Diego Center for Pain Medicine. He received the Migraine Research Foundation 2018 Impact Award to perform the first placebo-controlled trial of cannabis for acute migraine. He is a section editor for the Neuropathic Pain section of the journal Pain Medicine, the official journal of the American Academy of Pain Medicine. He is also a guest editor of the Pain & Headache: A Continuum issue for the journal Practical Neurology. His research focuses on clinical trials for headache and pain, including cannabinoid research.
For a limited time get up to 27% OFF all the 2025 interviews, videos, audio, transcripts, and more. Why upgrade?
- Can’t attend live? Watch anytime
- Prefer reading or listening? Get transcripts and audio
- Want to dive deeper? Explore the additional footage & resources
- Need ongoing support? Reference expert advice year-round
- Lifetime access to 2025, no annual fee
- Act now, early-bird offer ends March 19th!
Related Talks for: Day 4 (2025)
Exploring Lidocaine, Ketamine & More for Refractory Migraine
Shivang Joshi, MD, MPH, RPh
Brain Fog: Understanding the Cognitive Impacts of Migraine
Elizabeth (Betsy) Seng, PhD
